INVESTIGATING NOVEL BIOMARKERS FOR EARLY DISEASE DETECTION

Early identification of diseases is essential for improving patient outcomes and reducing the burden of chronic conditions. Traditionally, disease screening has relied on symptomatic observations and conventional diagnostic methods. However, these strategies often fail to pinpoint diseases in their preclinical stages, when treatment is significantl